Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Net Income: 2018-2024

Historic Net Income for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to -$322.1 million.

  • Avidity Biosciences' Net Income fell 117.13% to -$174.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$548.5 million, marking a year-over-year decrease of 95.95%. This contributed to the annual value of -$322.1 million for FY2024, which is 52.18% down from last year.
  • Latest data reveals that Avidity Biosciences reported Net Income of -$322.1 million as of FY2024, which was down 52.18% from -$211.6 million recorded in FY2023.
  • Avidity Biosciences' Net Income's 5-year high stood at -$44.3 million during FY2020, with a 5-year trough of -$322.1 million in FY2024.
  • Over the past 3 years, Avidity Biosciences' median Net Income value was -$211.6 million (recorded in 2023), while the average stood at -$235.9 million.
  • Data for Avidity Biosciences' Net Income shows a maximum YoY tumbled of 166.37% (in 2021) over the last 5 years.
  • Avidity Biosciences' Net Income (Yearly) stood at -$44.3 million in 2020, then crashed by 166.37% to -$117.9 million in 2021, then plummeted by 47.47% to -$173.9 million in 2022, then decreased by 21.67% to -$211.6 million in 2023, then plummeted by 52.18% to -$322.1 million in 2024.